Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (Advanced Cervical Cancer)

NCT06191900 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated from a business perspective.

Conditions

Adult
Gynecological Tumors

Interventions

BIOLOGICAL: Autologous tumor infiltrating lymphocyte injection（GT201）

Sponsor

Grit Biotechnology